Oxford BioMedica Delivering commercial gene-therapy vector – DirectorsTalk Interviews
|
Oxford BioMedica Delivering commercial gene–therapy vector
DirectorsTalk Interviews Hardman & Co Report Report Downloads Oxford BioMedica plc (LON:OXB) is a specialist gene and cell therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, whilst retaining its own proprietary therapeutic … Hardman: Delivering commercial gene–therapy vector |
